Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ysios Capital is a leading Spanish venture capital firm specialized in investments within the life sciences and healthcare sectors. Founded in 2008 and headquartered in Barcelona, the firm provides equity capital to early and mid-stage companies developing innovative disruptive therapies, medical devices, and diagnostics. Ysios manages several specialized funds, targeting companies with high unmet medical needs and clear exit potential through M&A or IPOs. Their investment strategy focuses on breakthrough science and strong management teams across Europe and North America. The firm maintains a diverse portfolio of international companies and is recognized for its deep domain expertise in the biotechnology ecosystem. Ysios often takes an active role in its portfolio companies, providing strategic guidance to drive clinical and commercial success.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ysios Asset Management.